Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.45 |
| ▸ | FGFR3 | P22607 | 11/20 | 0.43 |
| ▸ | KDR | P35968 | 10/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 10/20 | 0.43 |
| ▸ | FGFR2 | P21802 | 6/20 | 0.43 |
| ▸ | FGFR4 | P22455 | 6/20 | 0.43 |
| ▸ | FLT3 | P36888 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KIT | P10721 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6616314 | 1.00 | PDGFRB (0.45) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6617943 | 0.89 | PDGFRB (0.47) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6615937 | 0.88 | PDGFRB (0.43) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6620856 | 0.88 | KIT (0.44) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6617761 | 0.87 | PDGFRB (0.43) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6617430 | 0.87 | MET (0.44) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6617110 | 0.87 | MET (0.44) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| Dimethylamine SCHEMBL6620658 | 0.86 | PDGFRB (0.45) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6658013 | 0.86 | PDGFRB (0.41) | PDGFRBPDGFRAFGFR3KDRFGFR1 | |
| SCHEMBL6617252 | 0.85 | PDGFRB (0.50) | PDGFRBPDGFRAFGFR3KDRFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0779889-B1 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | AVENTIS PHARMA INC (US) | 2004-06-23 | — | — | EP | disclosed |
| EP-0779889-A4 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE POULENC RORER PHARMA (US) | 2000-02-23 | — | — | EP | disclosed |
| EP-0779889-A1 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-06-25 | — | — | EP | disclosed |
| WO-1996007658-A1 | PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-03-14 | — | — | WO | disclosed |
| US-5476851-A | Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1995-12-19 | — | — | US | disclosed |